https://integrateddiabetes.com/wp-content/uploads/2024/06/theresa-article.png
The Troubling Trend of Exploitative Diabetes Products and Putting Profit Over Patients
by, Theresa Hastings
Recently, I came across this product on social media. Clearly, a targeted ad for people with diabetes. While their intentions may be well-meaning, their offerings completely miss the mark, leaving those of us who actually live with the condition feeling unheard and misrepresented.
As people living with this condition, we are wise consumers, well aware of the multitude of challenges we face, from managing blood sugar levels that never seem to respond the same way as yesterday to navigating the illogical restrictions placed on us by health insurance companies.
Amidst this reality, a myriad of devices and tools flood the market, promising to make our lives easier. Yet, behind the glossy marketing lies a troubling trend: The core issue lies in a fundamental lack of understanding of diabetes and its intricacies. It’s not just about keeping insulin refrigerated; it’s about understanding how insulin behaves and what truly impacts its efficacy. Insulin doesn’t simply spoil the moment it’s not refrigerated; rather, it’s susceptible to temperature extremes, both high and low. This means that a $200 portable refrigerator isn’t the solution we need—it’s a fix for a problem that doesn’t actually exist.
What we truly need is recognition of the nuanced challenges we face and solutions that address them effectively. For instance, simple practices like keeping insulin out of direct sunlight and ensuring it’s stored in a cool, shaded place can often suffice. These aren’t revolutionary insights; they’re basic principles that many of us have learned through lived experience.
Yet, instead of amplifying these practical solutions, companies see dollar signs at the opportunity to capitalize on fear and misinformation, peddling unnecessary products at exorbitant prices. It’s a disheartening reality—one that speaks to the larger issue of profit-driven exploitation within the healthcare industry.
As individuals living with diabetes, we already bear a heavy financial burden. From medication costs to medical supplies, the expenses quickly add up. The last thing we need is to be taken advantage of by new companies pushing products looking to profit from our condition.
So, where do we go from here?
The most important first step is to empower ourselves with knowledge. By learning from each other and trustworthy experts, we can discern between genuine advancements and superficial gimmicks. Education and knowledge are our greatest weapons against exploitation.
We must also expect accountability from these companies. It’s not enough for them to superficially glance at our struggles and develop products that miss the mark. If they are worth giving our money to, they must elevate the voices of the diabetes community, listen to our wants and needs, and develop solutions that are truly beneficial, even if it means they don’t create a product to sell.
Ultimately, the issue at hand isn’t just about a single company or product—it’s about a broader pattern of exploitation within the healthcare landscape. Diabetes innovation should be led by our voices rather than our wallets.
Back to June 2024 NewsletterSign Up For The IDS Monthly Newsletter!
